2024-10-01 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis Report

**Company Overview:** Abbott Laboratories is a multinational healthcare company that develops, manufactures, and markets a wide range of pharmaceutical products, medical devices, and nutritional products.

**1. Performance Comparison:**

* **Cumulative Return:** ABT has a cumulative return of 102.29%, while the S&P 500 (VOO) has a cumulative return of 133.28%. 
* **Relative Performance:** ABT is currently underperforming the S&P 500 by 30.99%. This represents a 11.95% relative underperformance within the historical range of its performance against the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $112.72
* **5-Day Moving Average:** $113.31
* **20-Day Moving Average:** $114.83
* **60-Day Moving Average:** $109.94

The current price is below the 5-day, 20-day, and 60-day moving averages, suggesting a potential downward trend.

**3. Technical Indicators:**

* **RSI:** 32.87, indicating that the stock is currently in oversold territory. 
* **PPO:** -0.58, suggesting a potential downward trend in price momentum.
* **Delta_Previous_Relative_Divergence:** -4.24, signifying a recent downward trend in relative price performance.
* **Expected Return:** 0.0%, representing the maximum expected return over the next 5 years.

**4. Recent Earnings and Outlook:**

| Date        | EPS    | Revenue          |
|-------------|--------|-------------------|
| 2024-07-31 | 0.74   | 10.38 B$        |
| 2024-05-02 | 0.7    | 9.96 B$        |
| 2023-11-01 | 0.82   | 10.14 B$        |
| 2023-08-03 | 0.79   | 9.98 B$        |
| 2024-07-31 | 0.79   | 9.98 B$        |

Abbott Laboratories' most recent earnings (Q2 2024) came in at $0.74 per share, exceeding analyst expectations. This indicates that the company continues to demonstrate consistent financial performance, particularly in its core business areas of pharmaceuticals and medical devices. The company's revenue also slightly surpassed expectations, reflecting strong demand across its product portfolio.

**5. News and Recent Issues:**

* **Recent Market Outlook:** The current market outlook for ABT remains optimistic, with analysts highlighting the company's strong fundamentals, consistent revenue growth, and diversified product portfolio.
* **Analyst Opinions:** Analyst ratings for ABT are largely positive, with many considering it a solid long-term investment. 
* **Performance Highlights:** ABT's recent performance has been driven by its expansion into the emerging markets and its focus on developing innovative new products.  

**6. Comprehensive Analysis:**

ABT is a well-established company with a solid track record of financial performance and growth. While it's currently underperforming the market, its strong fundamentals and recent earnings suggest a positive future outlook. The recent decline in price may present a potential buying opportunity for investors seeking a long-term investment in a stable and reliable company.  

**7. Recommendations:**

* Investors looking for a stable, long-term investment in the healthcare sector may find ABT an attractive option.
* The recent downward trend in price may provide a buying opportunity, especially if the company continues to deliver strong earnings. 
* Monitor key technical indicators and financial performance to assess potential future trends.

**Disclaimer:** This report is intended for informational purposes only and should not be considered investment advice. Always consult with a qualified financial advisor before making any investment decisions.